XM does not provide services to residents of the United States of America.

FTSE 100 ends down as AstraZeneca slumps, US election in focus



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-FTSE 100 ends down as AstraZeneca slumps, US election in focus</title></head><body>

FTSE 100 down 0.1%, FTSE 250 down 0.5%

AstraZeneca falls on potential China probe

All eyes on U.S. election

British services PMI at 52 in Oct

Schroders slumps after Q3 results

Updated at 1650 GMT

By Pranav Kashyap and Nikhil Sharma

Nov 5 (Reuters) -Britain's benchmark FTSE 100 edged lower on Tuesday, hurt by AstraZeneca's fall on a potential China probe, while investors remained cautious as U.S. Election Day arrived.

The FTSE 100 .FTSE closed down 0.1% at 8,172.39 points, while the mid-cap FTSE 250 .FTMC fell 0.45% to 20,370.04 points

AstraZeneca AZN.L fell 8.4%, its biggest one-day drop since March 2020, following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.

On the flip side, Melrose Industries' MRON.L shares rose 5.1%, the best performer on the blue-chip index, after Citi raised the aerospace components supplier's free cash flow (FCF) forecast.

American voters headed to the polls on Tuesday to choose between Democrat Kamala Harris and Republican Donald Trump as the next U.S. president. The two were virtually tied in opinion polls, and the winner might not be known for days after voting ends. The outcome will likely be decided by a handful of so-called battleground states.

"A clear winner within the next day would be the ideal outcome here, while a long, drawn-out legal challenge is likely to keep bullish sentiment in check," said Chris Beauchamp, chief market analyst at online trading platform IG.

Following the high-stakes U.S. election, UK investors will shift focus to the Bank of England's policy meeting on Thursday, with traders pricing in a 25 basis-point rate cut.

A survey showed Britain's services sector lost some momentum in October, with business activity growing at the weakest rate in 11 months.

Among other stocks, Schroders SDR.L slumped about 14%, falling to the bottom of the FTSE 100, after the fund manager reported worse-than-expected outflows in the third quarter.

Associated British Foods ABF.L rose 3.2% after the Primark owner said it was well set up for medium-term growth, as it reported a 32% rise in full-year profit.

TP ICAP TCAPI.L gained 7% after the inter-dealer broker reported a 10% increase in its third-quarter revenue.



Reporting by Pranav Kashyap and Nikhil Sharma in Bengaluru
Editing by Tasim Zahid and Matthew Lewis

 For related prices, Reuters users may click on - * UK stock report .L FTSE index: 0#.FTS6 techMARK 100 index: .FTT1X FTSE futures: 0#FFI: Gilt futures: 0#FLG: Smallcap index: .FTSC FTSE 250 index: .FTMC FTSE 350 index: .FTLC Market digest: .AD.L Top 10 by vol: .AV.L Top price gainers: .NG.L Top % gainers: .PG.L Top price losers: .NL.L Top % losers: .PL.L * For related news, click on - * UK hot stocks: HOT and GB Wall Street: .N Gilts report: GB/ Euro bond report GVD/EUR Pan European stock report: .EU Tokyo stocks: .T HK stocks: .HK Sterling report: GBP/ Dollar report: USD/ * For company prices, click on - * Company directory: UKEQ By sector: FTAX * For pan-European market data, click on - * European Equities speed guide................ EUR/EQUITY FTSE Eurotop 300 index........................... .FTEU3 DJ STOXX index................................... .STOXX Top 10 STOXX sectors........................ .PGL.STOXXS Top 10 EUROSTOXX sectors................... .PGL.STOXXES Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S Top 25 European pct gainers.................... .PG.PEUR Top 25 European pct losers..................... .PL.PEUR
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.